|
|
|
|
pmid:
|
Altmann KH et al. |
Epothilones and related structures--a new class of microtubule inhibitors with potent in vivo antitumor activity. |
2000 |
Biochim. Biophys. Acta |
pmid:10799747
|
Chappell MD et al. |
En route to a plant scale synthesis of the promising antitumor agent 12,13-desoxyepothilone B. |
2000 |
Org. Lett. |
pmid:10841497
|
Stachel SJ et al. |
On the total synthesis and preliminary biological evaluations of 15(R) and 15(S) aza-dEpoB: a Mitsunobu inversion at C15 in pre-epothilone fragments. |
2000 |
Org. Lett. |
pmid:10841498
|
Mulzer J et al. |
Total syntheses of epothilones B and D. |
2000 |
J. Org. Chem. |
pmid:11076603
|
Altmann KH et al. |
Synthesis and biological evaluation of highly potent analogues of epothilones B and D. |
2000 |
Bioorg. Med. Chem. Lett. |
pmid:11133086
|
Sinha SC et al. |
Catalytic antibody route to the naturally occurring epothilones: total synthesis of epothilones A-F. |
2001 |
Chemistry |
pmid:11349910
|
White JD et al. |
Total synthesis of epothilone B, epothilone D, and cis- and trans-9,10-dehydroepothilone D. |
2001 |
J. Am. Chem. Soc. |
pmid:11389619
|
Chou TC et al. |
The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice. |
2001 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:11438750
|
Taylor RE and Chen Y |
Total synthesis of epothilones B and D. |
2001 |
Org. Lett. |
pmid:11440584
|
Hardt IH et al. |
New natural epothilones from Sorangium cellulosum, strains So ce90/B2 and So ce90/D13: isolation, structure elucidation, and SAR studies. |
2001 |
J. Nat. Prod. |
pmid:11473410
|
Lichtner RB et al. |
Subcellular distribution of epothilones in human tumor cells. |
2001 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:11562452
|
Hertweck C |
The multiplasmid approach: a new perspective for combinatorial biosynthesis. |
2000 |
Chembiochem |
pmid:11828403
|
Lau J et al. |
Optimizing the heterologous production of epothilone D in Myxococcus xanthus. |
2002 |
Biotechnol. Bioeng. |
pmid:11920444
|
Arslanian RL et al. |
Large-scale isolation and crystallization of epothilone D from Myxococcus xanthus cultures. |
2002 |
J. Nat. Prod. |
pmid:11975503
|
Arslanian RL et al. |
A new cytotoxic epothilone from modified polyketide synthases heterologously expressed in Myxococcus xanthus. |
2002 |
J. Nat. Prod. |
pmid:12141877
|
Julien B and Shah S |
Heterologous expression of epothilone biosynthetic genes in Myxococcus xanthus. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12183227
|
Chappell MD et al. |
Probing the SAR of dEpoB via chemical synthesis: a total synthesis evaluation of C26-(1,3-dioxolanyl)-12,13-desoxyepothilone B. |
2002 |
J. Org. Chem. |
pmid:12398496
|
Rivkin A et al. |
Total syntheses of [17]- and [18]dehydrodesoxyepothilones B via a concise ring-closing metathesis-based strategy: correlation of ring size with biological activity in the epothilone series. |
2002 |
J. Org. Chem. |
pmid:12398497
|
Kealey JT |
Creating polyketide diversity through genetic engineering. |
2003 |
Front. Biosci. |
pmid:12456305
|
Tang L et al. |
Generation of novel epothilone analogs with cytotoxic activity by biotransformation. |
2003 |
J. Antibiot. |
pmid:12670045
|
Verrills NM et al. |
Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactions. |
2003 |
Chem. Biol. |
pmid:12890533
|
Nagano S et al. |
Crystal structures of epothilone D-bound, epothilone B-bound, and substrate-free forms of cytochrome P450epoK. |
2003 |
J. Biol. Chem. |
pmid:12933799
|
Starks CM et al. |
Isolation and characterization of new epothilone analogues from recombinant Myxococcus xanthus fermentations. |
2003 |
J. Nat. Prod. |
pmid:14575429
|
Dietzmann A et al. |
Nanomolar concentrations of epothilone D inhibit the proliferation of glioma cells and severely affect their tubulin cytoskeleton. |
2003 |
J. Neurooncol. |
pmid:14686728
|
Altmann KH et al. |
4. The natural products epothilones A and B as lead structures for anticancer drug discovery: chemistry, biology, and SAR studies. |
2004 |
Prog Med Chem |
pmid:15003721
|
Schinzer D et al. |
Synthesis of furano-epothilone D. |
2004 |
Chemistry |
pmid:15224330
|
Kolman A |
Epothilone D (Kosan/Roche). |
2004 |
Curr Opin Investig Drugs |
pmid:15242255
|
Jumaa M et al. |
Kinetics and mechanism of degradation of epothilone-D: an experimental anticancer agent. |
2004 |
J Pharm Sci |
pmid:15459947
|
Jung JC et al. |
Total syntheses of epothilones B and d. |
2004 |
J. Org. Chem. |
pmid:15609966
|
Bergstralh DT et al. |
A comparison of signaling activities induced by Taxol and desoxyepothilone B. |
2004 |
J Chemother |
pmid:15700849
|
Gaich T and Mulzer J |
Synthesis of epothilones via a silicon-tethered RCM reaction. |
2005 |
Org. Lett. |
pmid:15787494
|
Broadrup RL et al. |
Total synthesis of 12,13-desoxyepothilone B (Epothilone D). |
2005 |
Bioorg. Chem. |
pmid:15788167
|
Wang H et al. |
Preclinical pharmacology of epothilone D, a novel tubulin-stabilizing antitumor agent. |
2005 |
Cancer Chemother. Pharmacol. |
pmid:15868148
|
Hause G et al. |
Epothilone D affects cell cycle and microtubular pattern in plant cells. |
2005 |
J. Exp. Bot. |
pmid:15967777
|
Frykman SA et al. |
Assessment of fed-batch, semicontinuous, and continuous epothilone D production processes. |
2005 Jul-Aug |
Biotechnol. Prog. |
pmid:16080689
|
Mutka SC et al. |
Heterologous production of epothilone C and D in Escherichia coli. |
2006 |
Biochemistry |
pmid:16430229
|
Wang Z et al. |
Determination of desoxyepothilone B in nude mice plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography. |
2006 |
J Pharm Biomed Anal |
pmid:16616824
|
Verrills NM et al. |
Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia. |
2006 |
J. Natl. Cancer Inst. |
pmid:17018783
|
End N et al. |
Total synthesis and biological evaluation of a C(10)/C(12)-phenylene-bridged analog of epothilone D. |
2004 |
Chem. Biodivers. |
pmid:17191815
|
Beer TM et al. |
Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel. |
2007 |
Invest New Drugs |
pmid:17618407
|
Fumoleau P et al. |
Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues. |
2007 |
Ann. Oncol. |
pmid:17656562
|
Kim TJ et al. |
Epothilone D, a microtubule-stabilizing compound, inhibits neointimal hyperplasia after rat carotid artery injury by cell cycle arrest via regulation of G1-checkpoint proteins. |
2007 |
Vascul. Pharmacol. |
pmid:17706465
|
Lee SH et al. |
Epothilones induce human colon cancer SW620 cell apoptosis via the tubulin polymerization independent activation of the nuclear factor-kappaB/IkappaB kinase signal pathway. |
2007 |
Mol. Cancer Ther. |
pmid:17938270
|
Harrison M and Swanton C |
Epothilones and new analogues of the microtubule modulators in taxane-resistant disease. |
2008 |
Expert Opin Investig Drugs |
pmid:18363517
|
Burris HA |
Preclinical investigations with epothilones in breast cancer models. |
2008 |
Semin. Oncol. |
pmid:18410795
|
Vahdat LT |
Clinical studies with epothilones for the treatment of metastatic breast cancer. |
2008 |
Semin. Oncol. |
pmid:18410796
|
Kuppens IE |
Current state of the art of new tubulin inhibitors in the clinic. |
2006 |
Curr Clin Pharmacol |
pmid:18666378
|
Zhang SQ et al. |
Determination of a novel epothilone D analog (AV-EPO-106) in human plasma using ultra-performance liquid chromatography-tandem mass spectrometry. |
2009 |
Biomed. Chromatogr. |
pmid:18800336
|
Keck GE et al. |
Total synthesis of epothilones B and D: stannane equivalents for beta-keto ester dianions. |
2008 |
J. Org. Chem. |
pmid:18991385
|
Chen QH et al. |
Design, synthesis and biological evaluation of bridged epothilone D analogues. |
2008 |
Org. Biomol. Chem. |
pmid:19039362
|
Prantz K and Mulzer J |
Decarboxylative Grob-type fragmentations in the synthesis of trisubstituted Z olefins: application to peloruside A, discodermolide, and epothilone D. |
2009 |
Angew. Chem. Int. Ed. Engl. |
pmid:19492384
|
Frein JD et al. |
New sources of chemical diversity inspired by biosynthesis: rational design of a potent epothilone analogue. |
2009 |
Org. Lett. |
pmid:19572566
|
Zhang C et al. |
Simultaneous determination of epothilone D and its hydrolytic metabolite in human plasma by high performance liquid chromatography-tandem mass spectrometry for pharmacokinetic studies. |
2009 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:19775943
|
Prantz K and Mulzer J |
Synthesis of (Z)-trisubstituted olefins by decarboxylative grob-type fragmentations: epothilone D, discodermolide, and peloruside A. |
2010 |
Chemistry |
pmid:19943284
|
Brunden KR et al. |
Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. |
2010 |
J. Neurosci. |
pmid:20943926
|
Brunden KR et al. |
The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies. |
2011 |
Pharmacol. Res. |
pmid:21163349
|
Monk JP et al. |
A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumors. |
2012 |
Invest New Drugs |
pmid:21826439
|
Nakano M et al. |
Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells. |
2011 |
Mol. Cell Proteomics |
pmid:21859949
|
Konner J et al. |
Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma. |
2012 |
Invest New Drugs |
pmid:22072399
|
Zhang B et al. |
The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. |
2012 |
J. Neurosci. |
pmid:22423084
|
Barten DM et al. |
Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027. |
2012 |
J. Neurosci. |
pmid:22623658
|
Brunden KR et al. |
Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies. |
2012 |
Biochem. Soc. Trans. |
pmid:22817712
|
Fournet V et al. |
Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice. |
2012 |
J. Neurochem. |
pmid:23013328
|
Wang C et al. |
Molybdenum-based complexes with two aryloxides and a pentafluoroimido ligand: catalysts for efficient Z-selective synthesis of a macrocyclic trisubstituted alkene by ring-closing metathesis. |
2013 |
Angew. Chem. Int. Ed. Engl. |
pmid:23307513
|
Xiong Y et al. |
HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:23487739
|
Cartelli D et al. |
Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotective. |
2013 |
Sci Rep |
pmid:23670541
|
Sang F et al. |
Epothilone D and its 9-Methyl analogues: combinatorial syntheses, conformation, and biological activities. |
2013 |
Eur J Med Chem |
pmid:23994325
|
Wessjohann LA et al. |
Total synthesis of epothilone D: the nerol/macroaldolization approach. |
2013 |
J. Org. Chem. |
pmid:24079664
|
Brunden KR et al. |
MT-Stabilizer, Dictyostatin, Exhibits Prolonged Brain Retention and Activity: Potential Therapeutic Implications. |
2013 |
ACS Med Chem Lett |
pmid:24900764
|
Yuan L et al. |
Use of a carboxylesterase inhibitor of phenylmethanesulfonyl fluoride to stabilize epothilone D in rat plasma for a validated UHPLC-MS/MS assay. |
2014 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:25151331
|
Brizuela M et al. |
The microtubule-stabilizing drug Epothilone D increases axonal sprouting following transection injury in vitro. |
2015 |
Mol. Cell. Neurosci. |
pmid:25684676
|
Burrell RC et al. |
Synthesis of stable isotope-labeled epothilone D using a degradation-reconstruction approach. |
2015 |
J Labelled Comp Radiopharm |
pmid:26158758
|
Killinger BA and Moszczynska A |
Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers. |
2016 |
J. Neurochem. |
pmid:26465779
|
Bakota L and Brandt R |
Tau Biology and Tau-Directed Therapies for Alzheimer's Disease. |
2016 |
Drugs |
pmid:26729186
|
Penazzi L et al. |
Aβ-mediated spine changes in the hippocampus are microtubule-dependent and can be reversed by a subnanomolar concentration of the microtubule-stabilizing agent epothilone D. |
2016 |
Neuropharmacology |
pmid:26772969
|
Ye W et al. |
A new approach for improving epothilone B yield in Sorangium cellulosum by the introduction of vgb epoF genes. |
2016 |
J. Ind. Microbiol. Biotechnol. |
pmid:26803504
|
Haydl AM and Breit B |
The Total Synthesis of Epothilone D as a Yardstick for Probing New Methodologies. |
2017 |
Chemistry |
pmid:27792853
|
Woods LM et al. |
Synthesis and Biological Evaluation of 7-Deoxy-Epothilone Analogues. |
2017 |
Int J Mol Sci |
pmid:28304361
|
Pchitskaya EI et al. |
Dynamic Microtubules in Alzheimer's Disease: Association with Dendritic Spine Pathology. |
2018 |
Biochemistry Mosc. |
pmid:30472945
|
Chou TC et al. |
Desoxyepothilone B: an efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9689134
|
Chou TC et al. |
Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9861050
|